WO2005026349A1 - 非アミノ有機酸の製造方法 - Google Patents
非アミノ有機酸の製造方法 Download PDFInfo
- Publication number
- WO2005026349A1 WO2005026349A1 PCT/JP2004/013658 JP2004013658W WO2005026349A1 WO 2005026349 A1 WO2005026349 A1 WO 2005026349A1 JP 2004013658 W JP2004013658 W JP 2004013658W WO 2005026349 A1 WO2005026349 A1 WO 2005026349A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- organic acid
- acid
- dna
- reaction
- Prior art date
Links
- -1 amino organic acid Chemical class 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims description 66
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 53
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 35
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 35
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 35
- 241000186254 coryneform bacterium Species 0.000 claims abstract description 33
- 239000012736 aqueous medium Substances 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims abstract description 24
- 239000000347 magnesium hydroxide Substances 0.000 claims abstract description 21
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims abstract description 21
- 150000001768 cations Chemical class 0.000 claims abstract description 15
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract description 11
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims abstract description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 5
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims abstract description 5
- 239000001530 fumaric acid Substances 0.000 claims abstract description 5
- 239000001630 malic acid Substances 0.000 claims abstract description 5
- 235000011090 malic acid Nutrition 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims description 59
- 238000004519 manufacturing process Methods 0.000 claims description 50
- 108010053763 Pyruvate Carboxylase Proteins 0.000 claims description 40
- 108010012901 Succinate Dehydrogenase Proteins 0.000 claims description 39
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 claims description 34
- 102000019259 Succinate Dehydrogenase Human genes 0.000 claims description 34
- 101710088194 Dehydrogenase Proteins 0.000 claims description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 25
- 239000008103 glucose Substances 0.000 claims description 25
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 18
- 229930006000 Sucrose Natural products 0.000 claims description 17
- 239000005720 sucrose Substances 0.000 claims description 17
- 150000007524 organic acids Chemical class 0.000 claims description 16
- 239000011368 organic material Substances 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 10
- 239000001569 carbon dioxide Substances 0.000 claims description 9
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 9
- 230000003472 neutralizing effect Effects 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 5
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 4
- 239000012298 atmosphere Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 229910001415 sodium ion Inorganic materials 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 238000003958 fumigation Methods 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 229940031958 magnesium carbonate hydroxide Drugs 0.000 abstract description 6
- 230000006698 induction Effects 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 118
- 238000006243 chemical reaction Methods 0.000 description 93
- 239000013612 plasmid Substances 0.000 description 74
- 239000002609 medium Substances 0.000 description 71
- 239000012634 fragment Substances 0.000 description 68
- 108090000623 proteins and genes Proteins 0.000 description 59
- 239000000243 solution Substances 0.000 description 59
- 241000588724 Escherichia coli Species 0.000 description 50
- 210000004027 cell Anatomy 0.000 description 49
- 108091008146 restriction endonucleases Proteins 0.000 description 38
- 235000014380 magnesium carbonate Nutrition 0.000 description 32
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 26
- 239000000203 mixture Substances 0.000 description 24
- 239000001384 succinic acid Substances 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 229930027917 kanamycin Natural products 0.000 description 20
- 229960000318 kanamycin Drugs 0.000 description 20
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 20
- 229930182823 kanamycin A Natural products 0.000 description 20
- 244000005700 microbiome Species 0.000 description 20
- 239000000725 suspension Substances 0.000 description 19
- 101150005926 Pc gene Proteins 0.000 description 18
- 238000007796 conventional method Methods 0.000 description 18
- 238000006386 neutralization reaction Methods 0.000 description 18
- 235000000346 sugar Nutrition 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 239000012153 distilled water Substances 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 239000013598 vector Substances 0.000 description 17
- 239000006142 Luria-Bertani Agar Substances 0.000 description 16
- 239000002773 nucleotide Substances 0.000 description 16
- 125000003729 nucleotide group Chemical group 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 14
- 238000009630 liquid culture Methods 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 13
- 235000019341 magnesium sulphate Nutrition 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 13
- 229920000936 Agarose Polymers 0.000 description 12
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 12
- 241000186031 Corynebacteriaceae Species 0.000 description 12
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- 238000005273 aeration Methods 0.000 description 12
- 101150038180 frd gene Proteins 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000001099 ammonium carbonate Substances 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 11
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 11
- 229940099596 manganese sulfate Drugs 0.000 description 11
- 239000011702 manganese sulphate Substances 0.000 description 11
- 235000007079 manganese sulphate Nutrition 0.000 description 11
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 11
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 11
- 229960000344 thiamine hydrochloride Drugs 0.000 description 11
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 11
- 239000011747 thiamine hydrochloride Substances 0.000 description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 238000010276 construction Methods 0.000 description 10
- 239000011790 ferrous sulphate Substances 0.000 description 10
- 235000003891 ferrous sulphate Nutrition 0.000 description 10
- 230000014509 gene expression Effects 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 210000000349 chromosome Anatomy 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000000246 agarose gel electrophoresis Methods 0.000 description 8
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 8
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 8
- 235000011130 ammonium sulphate Nutrition 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 150000004688 heptahydrates Chemical class 0.000 description 8
- 239000013600 plasmid vector Substances 0.000 description 8
- 230000010076 replication Effects 0.000 description 8
- 241000319304 [Brevibacterium] flavum Species 0.000 description 7
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 239000002518 antifoaming agent Substances 0.000 description 7
- 229940041514 candida albicans extract Drugs 0.000 description 7
- 235000005985 organic acids Nutrition 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 239000012138 yeast extract Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 241000186226 Corynebacterium glutamicum Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 5
- 241000186216 Corynebacterium Species 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 5
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000006801 homologous recombination Effects 0.000 description 5
- 238000002744 homologous recombination Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 4
- 241000186146 Brevibacterium Species 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000011007 phosphoric acid Nutrition 0.000 description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 description 4
- 235000011009 potassium phosphates Nutrition 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000012137 tryptone Substances 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 235000012501 ammonium carbonate Nutrition 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 101150018523 frdB gene Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000001477 organic nitrogen group Chemical group 0.000 description 3
- 229910001414 potassium ion Inorganic materials 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000012064 sodium phosphate buffer Substances 0.000 description 3
- 235000019710 soybean protein Nutrition 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 101100102503 Caenorhabditis elegans ver-3 gene Proteins 0.000 description 2
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000013530 defoamer Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- VNONBNKJWQLTMK-UHFFFAOYSA-K dimagnesium carboxylatooxycarbonyloxycarbonyl carbonate hydroxide pentahydrate Chemical compound O.O.O.O.O.[OH-].[Mg+2].C(=O)([O-])OC(=O)OC(=O)OC(=O)[O-].[Mg+2] VNONBNKJWQLTMK-UHFFFAOYSA-K 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000012262 fermentative production Methods 0.000 description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000722955 Anaerobiospirillum Species 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101001120470 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Peptidoglycan-associated lipoprotein Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241001148115 Rhizobium etli Species 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- KPUBIZJWWGSWGQ-UHFFFAOYSA-N azane;carbonic acid Chemical compound N.N.N.OC(O)=O.OC(O)=O KPUBIZJWWGSWGQ-UHFFFAOYSA-N 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 101150075213 frdA gene Proteins 0.000 description 1
- 101150087653 frdC gene Proteins 0.000 description 1
- 101150023570 frdD gene Proteins 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 101150104734 ldh gene Proteins 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- PXECIQXWUBSKSW-UHFFFAOYSA-L magnesium dihydroxide pentahydrate Chemical compound O.O.O.O.O.[OH-].[OH-].[Mg++] PXECIQXWUBSKSW-UHFFFAOYSA-L 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- JSPANIZMKMFECH-UHFFFAOYSA-L manganese(II) sulfate dihydrate Chemical compound O.O.[Mn+2].[O-]S([O-])(=O)=O JSPANIZMKMFECH-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000012134 supernatant fraction Substances 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
Definitions
- the present invention relates to production of non-amino organic acids using coryneform bacteria.
- Anaerobic bacteria such as the genus Anaerobiospirillum and the genus Actinobacillus are used! /, Ru (U.S. Pat.No. 5,142,834, U.S. Pat.No. 5,504,004 or International Journal of Systematic Bacteriology (1999), vol. 49, p207-216).
- Ru U.S. Pat.No. 5,142,834, U.S. Pat.No. 5,504,004 or International Journal of Systematic Bacteriology (1999), vol. 49, p207-216.
- CSL corn steep liquor
- a nitrogen source needs to be added. Adding a large amount of these organic nitrogen sources not only increased the cost of the culture medium, but also increased the purification cost when removing unsatisfactory products.
- aerobic bacteria such as coryneform bacteria are cultured once under aerobic conditions, and after the cells are grown, the cells are collected and washed, and as non-amino amino acids are passed as static cells without aeration with oxygen.
- Methods for producing organic acids are also known (JP-A-11-113588, JP-A-11-196888).
- JP-A-11-113588, JP-A-11-196888 Methods for producing organic acids.
- An object of the present invention is to provide a method for producing a non-amino organic acid more efficiently by adjusting the pH of a fermentation liquor to a certain range by a fermentation method.
- the present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, the coryneform bacterium was neutralized with magnesium carbonate and Z or magnesium hydroxide in an aqueous medium.
- the aqueous medium By reacting the aqueous medium with an organic material, it has been found that an increase in the volume of the aqueous medium during fermentation can be prevented, and that the non-amino organic acid can be produced while maintaining the pH of the medium in a certain range.
- they have found that the coexistence of a monovalent cation in an aqueous medium increases the consumption rate of organic raw materials, the production rate of organic acids, and the yield, and has completed the present invention.
- a method for producing a non-amino organic acid comprising: reacting the cells or treated product with an organic raw material while neutralizing the aqueous medium with magnesium carbonate and Z or magnesium hydroxide.
- coryneform bacterium is a bacterium modified such that ratatate dehydrogenase activity is reduced to 10% or less as compared with an unmodified strain.
- coryneform bacterium is a bacterium modified to enhance the activity of fumarate reductase and Z or pyruvate carboxylase.
- the coryneform bacterium has a ratate dehydrogenase activity of 1
- a non-amino acid comprising a step of producing a non-amino organic acid by any one of (10) and a step of performing a polymerization reaction using the non-amino organic acid obtained in the above step as a raw material.
- a method for producing an organic acid-containing polymer A method for producing an organic acid-containing polymer.
- FIG. 1 is a diagram showing a construction procedure of a plasmid pKMBl and a restriction enzyme map.
- FIG. 2 is a diagram showing a procedure for constructing a plasmid ⁇ LDH.
- FIG. 3 is a view showing a procedure for constructing a plasmid pTZ4.
- FIG. 4 is a view showing a procedure for constructing a plasmid pMJPCl.
- FIG. 5 is a view showing a procedure for constructing a plasmid pFRPCl.
- a coryneform bacterium or a processed product of the bacterium is reacted with an organic raw material in an aqueous medium to generate a non-amino organic acid from the organic raw material.
- the coryneform bacterium used in the present invention is a non-organic organic acid Although it is not particularly limited as long as it has a productivity, a microorganism belonging to the genus Corynepacterium, a microorganism belonging to the genus Brevinocterium or a microorganism belonging to the genus Arthrobacter can be mentioned.
- the genus Corynebacterium or Brevi those belonging to the genus Batterium, more preferably Corynebacterium glutamicum (Corynebacterium glutamicum), Brevibacterium flavum (Brevibacterium flavum), Brevibacterium ammoniagenes (Brevibacterium ammoniagenes) or Microorganisms belonging to Brevibacterium lactofermentum.
- Corynebacterium glutamicum Corynebacterium glutamicum
- Brevibacterium flavum Brevibacterium flavum
- Brevibacterium ammoniagenes Brevibacterium ammoniagenes
- Microorganisms belonging to Brevibacterium lactofermentum preferably, those belonging to the genus Batterium, more preferably Corynebacterium glutamicum (Corynebacterium glutamicum), Brevibacterium flavum (Brevibacterium flavum), Brevibacterium ammoniagenes (Brevibacterium ammoniagenes) or Microorganisms belonging to
- Brevibataterum 'Flavum MJ-233 was established on April 28, 1975, by the Institute of Microbial Industry and Technology, the Ministry of International Trade and Industry (currently the National Institute of Advanced Industrial Science and Technology, Patent Organism Depositary) (Dr. 305-8566 Japan Deposit No. FERM P-3068 at Tsukuba East 1-chome, Ibaraki Pref., Japan 1), transferred to an international deposit under the Budapest Treaty on May 1, 1981, and received FERM BP-1497 Deposited by number.
- Brevibataterum 'Flavum' is sometimes classified as Corynebataterimum 'Daltamicum' (Lielbl, W., Ehrmann, M., Ludwig, W. and Schleifer, KH, International Journal of Systematic Bacteriology, 1991, vol. 41, p. 255-260), and in the present invention, the MJ-233 and MJ-233 AB-41 strains of Brevibataterum 'Flavum' are respectively Corynebataterum 'glutamicum. MJ-233 and MJ-233 AB-41.
- the microorganism used in the method of the present invention may be a mutant obtained by ordinary mutation treatment such as UV irradiation or NTG treatment, or a genetic method such as cell fusion or gene recombination, which can be performed by using only wild-type strains. Any strain such as an induced recombinant strain may be used. As a host of the genetically modified strain, any transformable microorganism can be used. Although it may be of the same genus as the parent strain or of a different genus, it is preferable to use the aerobic bacterium as described above as a host.
- the ratate dehydrogenase activity is reduced means that the lactate dehydrogenase activity per cell is reduced as compared with a non-modified ratate dehydrogenase strain. It is preferable that the ratate dehydrogenase activity is reduced to 10% or less per bacterial cell, as compared with the unmodified ratate dehydrogenase strain. Further, the ratate dehydrogenase activity may be completely deficient.
- ratate dehydrogenase activity was reduced was determined by measuring ratate dehydrogenase activity by a known method (L. Kanarek and R ⁇ . Hill, J. Biol. Chem. 239, 4202 (1964)). Can be confirmed by As a specific method for producing a mutant strain having reduced ratatate dehydrogenase activity of a coryneform bacterium, a method by homologous recombination into a chromosome described in JP-A No. 11-206385 is used. Methods using the SacB gene described in the specification examples (Schafer, A. et al. Gene 145 (1994) 69-73) and the like can be mentioned.
- a coryneform bacterium modified so as to enhance the activity of fumarate reductase (FRD) and Z or pyruvate carboxylase (PC) can also be used.
- the term “enhancement” refers to a state in which the activity of these enzymes per cell is increased as compared with the unmodified strain.
- Escherichia coli fumarate reductase is an enzyme responsible for the reverse reaction of succinate dehydrogenase acting in the TCA cycle, but is involved in fumarate respiration under anaerobic conditions and is aerobic.
- the PC gene used to enhance the PC activity may be a gene whose base sequence has already been determined, or a DNA fragment encoding a protein having a PC activity by a conventional method, which is obtained by removing chromosomes from microorganisms, animals and plants. Those which have been more isolated and whose nucleotide sequence has been determined can be used. After the nucleotide sequence is determined, a gene synthesized according to the sequence can also be used.
- the DNA fragment containing the PC gene is present on chromosomes derived from microorganisms, animals and plants.
- the basic operation for preparing a PC gene from these source microorganisms, animals and plants is as follows, as an example, using a coryneform bacterium whose sequence is known.
- the PC gene is present on the chromosome of the above-mentioned coryneform bacterium, Corynebacterium dartamicam ATCC13032 (Peters-Wendisch, PG et al. Because of this (GenBank Database Accession No. AP005276) (SEQ ID NO: 15), the PC gene can be isolated and obtained by the PCR method.
- a chromosome derived from Corynebacterium dalmatamicum is used as a primer with an oligonucleotide having the nucleotide sequence shown in SEQ ID NO: 13 or 14 as a primer for PCR
- PCR is performed, the resulting DNA is about 3.7 kb.
- a powerful PC gene can be amplified.
- by adding an appropriate restriction enzyme site to the 5 'end of the primer used for PCR it can be ligated to an appropriate site of the vector described later, and the obtained recombinant vector can be used. Can be introduced into coryneform bacteria.
- the protein is purified using the PC activity as an index, and a probe or primer is synthesized from the N-terminal amino acid sequence and the partially degraded sequence.
- Gene fragments can be isolated by the technique of Chillon.
- a probe or primer is synthesized based on the amino acid sequence of the region conserved between PC proteins, and Fragments can be obtained by bridging or PCR. The DNA sequence of the obtained fragment can be determined by an ordinary method.
- the DNA of the Escherichia coli 'lambda' phage can be obtained by digesting the DNA with the restriction enzyme Hindlll.
- Escherichia coli coli 174 phage DNA fragments of known molecular weight obtained by cleaving DNA with the restriction enzyme Haelll based on the standard line drawn by the migration distance on the same polyacrylamide gel. The size can be calculated.
- the DNA fragment containing the PC gene used in the present invention is not limited to that isolated from Corynebate terridium 'Daltam chromosome chromosomal DNA', but also a commonly used DNA synthesizer such as Applied 'Biosystems (Applied Biosystems). Biosystems) 394 DNA / RNA synthesizer.
- the PC gene obtained from the coryneform bacterial chromosome DNA has the sequence of SEQ ID NO: 15 as long as it does not substantially impair the function of the encoded PC, that is, the property involved in immobilizing carbon dioxide.
- some bases may be replaced or deleted with other bases, or a new base may be inserted.
- DNA that hybridizes with DNA having the nucleotide sequence of SEQ ID NO: 15 under stringent conditions or 90% or more, preferably 95% or more, more preferably 99% or more homology with the nucleotide sequence of SEQ ID NO: 15 DNA encoding a protein having PC activity and having PC activity can also be suitably used.
- stringent conditions 60 ° C., 1 ⁇ SSC, 0.1% SDS, preferably 0.1 ⁇ SSC, 0.1 ⁇ SSC, which is a normal condition for washing southern hybridizations, are used.
- PC genes derived from bacteria other than Corynebacterium 'daltamicum, or from other microorganisms or animals and plants can also be used.
- sequences of PC genes derived from microorganisms or animals and plants shown below are known (the references are shown in parentheses), and their ORFs can be replaced by hybridization or PCR as described above. It can be obtained by amplification.
- the obtained gene can be inserted downstream of the TZ4 promoter in the vector prepared in Example 3 described later.
- An aerobic coryneform bacterium can be transformed with the inserted plasmid according to the method of Example 4 (C) and used for production of a non-amino organic acid.
- the DNA fragment containing the PC gene is inserted into an appropriate expression plasmid, for example, pUC118 (Takara Shuzo), and introduced into an appropriate host microorganism, for example, Escherichia coli JM109 (Takara Shuzo).
- an appropriate expression plasmid for example, pUC118 (Takara Shuzo)
- Escherichia coli JM109 Teakara Shuzo
- SEQ ID NO: 16 was carried out by extracting a crude enzyme solution from the transformant and using the method of Magasanik [J. Bacteriol., 158, 55-62, (1984) ] Can be confirmed by directly measuring the PC activity and comparing it with the PC activity of the crude enzyme solution which has not been transformed.
- the DNA fragment containing the PC gene is introduced into a suitable plasmid, for example, a plasmid vector containing at least a gene that controls the replication and growth function of the plasmid in the coryneform bacterium.
- a suitable plasmid for example, a plasmid vector containing at least a gene that controls the replication and growth function of the plasmid in the coryneform bacterium.
- An expressible recombinant plasmid can be obtained.
- the promoter for expressing the PC gene is a force S that can be a promoter possessed by a coryneform bacterium, and is not limited to such a base sequence for initiating transcription of the PC gene. If so, a suitable promoter may be used.
- a TZ4 promoter as shown in Example 3 can be mentioned.
- the plasmid vector into which the PC gene can be introduced is not particularly limited as long as it contains at least a gene that controls the replication and growth function in coryneform bacteria. Specific examples thereof include, for example, plasmid pCRY30 described in JP-A-3-210184; plasmids pCRY21, pCRY2KE, pCRY2KX described in JP-A-2-72876 and US Pat. No. 5,185,262.
- pCRY31, pCRY3KE and pCRY3KX plasmids pCRY2 and pCRY3 described in JP-A-1-191686; JP-A-58-67679; pAM330 described herein; JP-A-58-77895; pHM1519 described PAJ655, pAJ611 and pAJ1844 described in JP-A-58-192900; pCGl described in JP-A-57-134500; pCG2 described in JP-A-58-35197; Examples include pCG4 and pCGll described in 183799.
- plasmid vectors used in a coryneform bacterium host vector system include a gene that controls replication and propagation of a plasmid in a coryneform bacterium and a gene that controls a plasmid stabilization function in a coryneform bacterium.
- plasmids having plasmids pCRY30, pCRY21, pCRY2KE, pCRY2KX, pCRY31, pCRY3KE, and pCRY3KX are preferably used.
- a coryneform bacterium with enhanced PC gene expression used in the present invention can be obtained.
- the PC activity can also be enhanced by introducing, replacing, or amplifying a PC gene on a chromosome by a known homologous recombination method to increase the expression. Transformation, for example For example, it can be performed by the electric pulse method (Res. Microbiol, Vol. 144, p. 181-185, 1993).
- the bacterium with enhanced FRD activity used in the present invention can be obtained by introducing an FRD gene into the bacterium.
- the FRD gene that can be used is not particularly limited as long as it encodes a protein having fumarate reductase activity, and examples thereof include a gene derived from Escherichia coli having the nucleotide sequence shown in SEQ ID NO: 19. This gene contains the genes encoding the four subunits (frdA, frdB, frdC, and frdD; SEQ ID NOs: 20 and 23) that constitute the FRD (SEQ ID NO: 19, 440—2245,2241—2975,2986—3381, and And operon genes including 3392-3751), respectively.
- Each subunit gene may be a DNA that hybridizes with a DNA having the above nucleotide sequence under stringent conditions, or a DNA that hybridizes, as long as it encodes a subunit protein capable of forming a complex having FRD activity. It may be a homolog having 90% or more, preferably 95% or more, more preferably 99% or more homology with the nucleotide sequence.
- stringent conditions 60 ° C., 1 ⁇ SSC, 0.1% SDS, preferably 0.1 ⁇ SSC, 0 ° C., which is a condition for washing ordinary Southern hybridizations, are used.
- FRD gene homologs those encoding a protein in which the amino acid corresponding to the 17th amino acid of the B subunit (frdB) of FRD (SEQ ID NO: 21) is lysine are preferable.
- the gene having the nucleotide sequence shown in SEQ ID NO: 19 or a homolog thereof can be obtained by a PCR method or a hybridization method. Further, if necessary, a mutation such that the amino acid corresponding to the 17th amino acid of frdB is lysine can be introduced by a known method.
- FRD genes derived from bacteria other than Escherichia coli, or from other microorganisms or animals and plants can also be used.
- the FRD gene derived from a microorganism or animal or plant has its nucleotide sequence already determined, and, based on the gene, homology, etc., isolates a gene encoding a protein having FRD activity from the chromosome of the microorganism, animal or plant, etc. Those whose base sequence has been determined can be used. After the base sequence has been determined, a gene synthesized by force according to the sequence can also be used. These are based on the hybridization method or P It can be obtained by amplifying the region containing the promoter and the ORF portion by the CR method.
- the FRD of the FRD gene is introduced in the coryneform bacterium.
- a recombinant plasmid capable of enhancing expression can be obtained.
- the plasmid vector into which the FRD gene can be introduced into the coryneform bacterium is not particularly limited as long as it contains at least a gene that controls the replication growth function in the coryneform bacterium, and the above-described pCRY30, pCRY21, etc. may be used. be able to.
- the FRD activity can also be enhanced by introducing, replacing, or amplifying the FRD gene on the chromosome by a known homologous recombination method to thereby achieve high expression.
- the fumarate reductase activity is desirably enhanced to such an extent that the growth of the bacterial cells is not significantly inhibited, so that a plasmid having an appropriate copy number should be selected. It is preferable to control the expression level of the FRD gene by selecting a promoter having an appropriate expression intensity.
- the promoter for expressing the FRD gene may be any promoter as long as it functions in coryneform bacteria, and may be the promoter of the FRD gene itself to be used.
- a bacterium having enhanced PC and FRD activities when used, these genes may be individually introduced into the bacterium, or may be introduced simultaneously using a vector containing both genes. You may.
- a bacterium modified so that the activity of ratate dehydrogenase is reduced and the activity of PC and Z or FRD is enhanced Such a bacterium can be obtained, for example, by preparing a coryneform bacterium in which the LDH gene has been disrupted, and transforming the obtained bacterium with a recombinant vector containing the PC gene and the FRD gene. Any modification operation using these genes may be performed first.
- a cultivation of the bacterium in a solid medium such as an agar medium on a slant may be used directly for the reaction. It is preferable to use one that has been used.
- Non-amino organic acids are produced by reacting the seed-cultured bacteria with the organic materials while growing them in a medium containing the organic materials. can do.
- the cells can be produced by reacting the cells obtained by the propagation with an organic material in an aqueous solution containing the organic material.
- a medium usually used for culturing microorganisms can be used.
- a general medium in which a natural nutrient such as a meat extract, a yeast extract, and peptone is added to a composition comprising inorganic salts such as ammonium sulfate, potassium phosphate, and magnesium sulfate can be used.
- the cultured cells are recovered by centrifugation, membrane separation, etc., and used for the reaction.
- a processed product of bacterial cells can also be used.
- the processed cells are, for example, immobilized cells obtained by immobilizing cells with acrylamide, carrageenan, etc., cell extracts, for example, crushed cells obtained by crushing cells, centrifuged supernatant thereof, or Fractions obtained by partially purifying the supernatant by ammonium sulfate treatment or the like can be given.
- the organic raw material used in the production method of the present invention is not particularly limited as long as it is a carbon source capable of assimilating the non-amino organic acid by the present microorganism, and usually, galactose, ratatose, gnorecose, funolectose, and glycerolone are used.
- Carbohydrates such as sucrose, sucrose, starch, and cellulose; and fermentable sugars such as polyalcohols such as glycerin, mannitol, xylitol, and ribitol, and glucose, sucrose, fructose, or glycerol is preferred.
- glucose or sucrose is preferred.
- starch saccharified solution, molasses and the like containing the above-mentioned fermentable carbohydrate are also used.
- the use concentration of the organic raw material is not particularly limited !, but it does not inhibit the production of organic acid! It is advantageous to use as high as possible in the range, and usually, it can be used within the range of 5 to 30% (WZV), preferably 10 to 20% (WZV). Further, an additional organic material may be added in accordance with the decrease in the amount of the organic material as the reaction proceeds.
- the aqueous medium used in the production method of the present invention is not particularly limited, and includes, for example, water, a buffer solution, and a liquid medium.
- the liquid medium as described above is most preferable.
- the aqueous medium of the present invention preferably contains a nitrogen source, an inorganic salt, and the like.
- the nitrogen source is not particularly limited as long as the microorganism can assimilate and produce a non-amino organic acid.
- Specific examples include, but are not limited to, various organic and inorganic nitrogen compounds such as ammonium salts, nitrates, urea, soybean hydrolysates, hydrolyzed zein, peptone, yeast extract, meat extract, and corn steep liquor.
- vitamins such as biotin, pantothenic acid, inositol and nicotinic acid, nucleotides, amino acids and other factors promoting growth may be added as necessary. It is also desirable to add an appropriate amount of a commercially available antifoaming agent to the aqueous medium in order to suppress foaming during the reaction.
- an aqueous medium is reacted while being neutralized by adding magnesium carbonate.
- Magnesium carbonate exists as magnesium tetracarbonate monohydroxide magnesium pentahydrate and is relatively insoluble in water.
- Magnesium carbonate added to an aqueous medium can be added by adding a solution dissolved in a solid such as powder or water, etc.It was possible to prevent an increase in volume due to the added solution of the solution. Therefore, it is preferable to add it as a solid such as a powder.
- Magnesium carbonate added as a powder has a low solubility, so that even if it is added in excess, it is possible to maintain a constant pH without being too alkaline.
- the initial pH is about pH8-8.5, and then the pH decreases as the reaction proceeds. Is maintained at about pH 6-7. This is considered to prevent the magnesium carbonate, which was added in excess and remained dissolved during the reaction, from gradually dissolving and preventing the pH from dropping sharply.
- the aqueous medium may be reacted while neutralizing the aqueous medium by adding magnesium hydroxide.
- the addition of magnesium hydroxide to an aqueous medium can be carried out, for example, in the form of a solid such as a powder or a solution dissolved in water or the like. In this case, it is preferable to carry out the reaction while supplying carbon dioxide gas in order to increase the production amount of the target organic acid.
- the reaction may be carried out while neutralizing the aqueous medium by adding magnesium carbonate and magnesium hydroxide.
- the addition of magnesium carbonate and magnesium hydroxide may be performed simultaneously for neutralization, or magnesium carbonate may be added and then magnesium hydroxide added for neutralization. Oxidation After adding gnesium, magnesium carbonate may be added to neutralize the mixture.
- neutralization means that the non-amino organic acid produced by the reaction is reacted with magnesium carbonate and Z or magnesium hydroxide to adjust the pH of the aqueous medium to a certain range, for example, pH 5 to 10%. 10, preferably maintaining the pH at 6-9.5.
- magnesium carbonate and / or magnesium hydroxide may be added first, or may be further removed as needed during the reaction.
- another pH adjusting substance for example, an alkaline substance, a carbonate, or urine may be added.
- the aqueous medium contains carbonate ions, bicarbonate ions or carbon dioxide gas, and is reacted under aerobic or anaerobic conditions.
- the carbonate ion or bicarbonate ion is also supplied with magnesium carbonate power used as a neutralizing agent, but may be supplied with carbonic acid or bicarbonic acid or salts thereof or carbon dioxide gas power as required.
- Specific examples of salts of carbonic acid or bicarbonate include, for example, magnesium carbonate, ammonium carbonate, sodium carbonate, potassium carbonate, ammonium bicarbonate, sodium bicarbonate, potassium bicarbonate and the like.
- the carbonate ion and bicarbonate ion may be added at a concentration of 0.001 to 5M, preferably 0.1 to 3M, and more preferably 12 to 12M.
- carbon dioxide When carbon dioxide is contained, 50 mg to 25 g, preferably 100 mg to 15 g, and more preferably 150 mg to 10 g per 1 L of the solution may be contained.
- the generation rate or yield of an organic acid such as succinic acid can be increased.
- an ammonium ion such as an ammonium ion, a sodium ion or a potassium ion is preferably used.
- a monovalent cation hydroxide such as sodium hydroxide, sodium hydroxide, calcium hydroxide, etc.
- a salt of an ammonium ion which is preferably added as a salt
- sodium bicarbonate is used as a salt of an ammonium bicarbonate, an ammonium salt of a salt, an ammonium salt of a sulfate, etc.
- Isopotassium Salts of potassium ions include potassium bicarbonate.
- a salt of a monovalent cation When a salt of a monovalent cation is added, it is usually added in the form of a powder or a suspension thereof. Alternatively, it is preferably added as an aqueous solution. In addition, when adding hydroxylamine, it may be added as aqueous ammonia, or may be added as a gas by aeration in the reaction solution.
- the concentration of the monovalent cation added is 0.001M to 2M, preferably 0.01M to 1M, as the ammonium ion, and 0.001M to 2M, preferably 0.01M to 1M as the sodium ion.
- the potassium ion is 0.001M-2M, preferably 0.01M-1M.
- the monovalent cation may be added at the start of the reaction, or may be added continuously, sequentially or intermittently during the reaction.
- the reaction solution is used continuously, considering the amount of the monovalent cation already added to the reaction solution, add it so that the concentration of the monovalent cation in the reaction solution becomes the above-mentioned concentration, preferably. I prefer that.
- the optimal growth temperature of the microorganism used in this reaction is usually 25 ° C to 35 ° C.
- the temperature during the reaction is usually 25 ° C to 40 ° C, preferably 30 ° C to 37 ° C.
- the amount of the cells used in the reaction is not particularly limited, but is used in an amount of 1 to 700 gZL, preferably 10 to 500 gZL, and more preferably 20 to 400 gZL.
- the reaction time is preferably 1 hour to 168 hours, more preferably 3 hours to 72 hours.
- the production reaction of the organic acid may be carried out with aeration and stirring, but may be carried out without aeration and without supplying oxygen, or may be carried out in an anaerobic atmosphere in which the ventilation is restricted and the oxygen supply amount is restricted.
- the term "under an anaerobic atmosphere” as used herein means that the reaction is carried out while keeping the dissolved oxygen concentration in the solution low. In this case, it is desirable to carry out the reaction at a dissolved oxygen concentration of 0 to 2 ppm, preferably 0 to 1 ppm, more preferably 0 to 0.5 ppm.
- Methods for this purpose include, for example, a method in which the container is sealed and reacted without aeration, a reaction is performed by supplying an inert gas such as nitrogen gas, a method in which an inert gas containing carbon dioxide gas is passed, and stirring is reduced. Can be used.
- the reaction for producing an organic acid can be usually terminated when an organic raw material such as glucose in a culture solution is consumed. At this time, an organic acid such as succinic acid, malic acid or fumaric acid is generated in the reaction solution. Of these, succinic acid has the highest accumulation and is preferred as a product.
- succinic acid has the highest accumulation and is preferred as a product.
- an organic acid such as succinic acid, malic acid or fumaric acid can be obtained.
- This organic acid-containing composition itself is also within the scope of the present invention.
- the organic acid-containing composition those having a high accumulation concentration of cono and citric acid are particularly preferable.
- the organic acid accumulated in the reaction solution or the culture solution can be separated and purified according to a conventional method. Specifically, after removing solids such as bacterial cells by centrifugation, filtration, etc., desalting with ion-exchange resin, etc., and the organic acid is separated and purified by crystallization or column chromatography. Can be done
- a non-amino organic acid-containing polymer is produced by producing a non-amino organic acid by the above-mentioned method of the present invention and then conducting a polymerization reaction using the obtained non-amino organic acid as a raw material.
- the non-amino organic acids produced in the present invention are processed into polymers such as polyesters and polyamides. It can be used.
- the non-amino organic acid or the composition containing the non-amino organic acid obtained by the production method of the present invention can be used as a food additive, a pharmaceutical, or a cosmetic.
- Bacillus subtilis ISW1214 was cultured in 10 mL of LB medium [composition: 10 g of tryptone, 5 g of yeast extratato, and 5 g of NaCl in 1 L of distilled water] until the late logarithmic growth phase, and the cells were collected. The obtained cells were suspended in 0.15 mL of 10 mM NaC1 20 mM Tris buffer (pH 8.0) -lmM EDTA'2Na solution containing lysozyme at a concentration of 10 mgZmL.
- proteinase K was added to the above suspension so that the final concentration became 100 gZmL, and the mixture was incubated at 37 ° C. for 1 hour. Further, sodium dodecyl sulfate was added to a final concentration of 0.5%, and the cells were lysed by keeping the temperature at 50 ° C for 6 hours. Add an equal volume of phenol to this lysate Add the Z-chloroform solution, gently shake at room temperature for 10 minutes, then centrifuge the whole (5,000 X g, 20 minutes, 10-12 ° C), collect the supernatant fraction, and add sodium acetate Was added to a concentration of 0.3 M, and then twice the amount of ethanol was mixed with the mixture.
- the precipitate collected by centrifugation (15,000 ⁇ g, 2 minutes) was washed with 70% ethanol and air-dried. 5 mL of a 10 mM Tris buffer solution (pH 7.5) —ImM EDTA ′ 2Na solution was added to the obtained DNA, and the mixture was allowed to stand at 4 ° C. for use as a type I DNA for subsequent PCR.
- the Bacillus subtilis SacB gene was obtained by converting the DNA prepared in (A) above into type III and designing a synthetic DNA (SEQ ID NO: 2) designed based on the previously reported base sequence of the gene (GenBank Database Accession No. X02730). PCR was performed using 1 and SEQ ID NO: 2).
- Reaction solution composition Type 1 DNA 1 ⁇ L, Pfx DNA polymerase (manufactured by Invitrogen) 0.2 ⁇ L, 1-fold concentration attached buffer, 0.3 M each primer, ImM MgSO
- MdNTPs were mixed to make a total volume of 20 L.
- Reaction temperature conditions Using a DNA Thermal Cycler PTC-200 (manufactured by MJ Research), a cycle consisting of 94 ° C for 20 seconds and 68 ° C for 2 minutes was repeated 35 times. However, the heat retention at 94 ° C in the first cycle was 1 minute and 20 seconds, and the heat retention at 68 ° C in the final cycle was 5 minutes.
- the amplification product was confirmed by separating it by 0.75% agarose (SeaKem G TG agarose: manufactured by FMC BioProducts) gel electrophoresis, and then visualizing it by staining with bromide chidium to detect a fragment of about 2 kb.
- the target DNA fragment was recovered using a QIAQuick Gel Extraction Kit (manufactured by QIAGEN).
- the recovered DNA fragment was phosphorylated at the 5 'end with T4 polynucleotide kinase (T4 Polynucleotide Kinase: manufactured by Takara Shuzo), and then ligated using Ligation Kit ver. 2 (Takara Shuzo).
- Escherichia coli DH5a strain
- was transformed with the obtained plasmid DNA by binding to the EcoRV site of an E. coli vector (pBluescriptll: manufactured by STRATEGENE). The recombinant E.
- coli thus obtained is spread on an LB agar medium containing 50 ⁇ g ZmL ampicillin and 50 ⁇ g ZmL X-Gal [dissolve 10 g of tryptone, 5 g of yeast extratato, 5 g of NaCl, and 15 g of agar in 1 L of distilled water]. did.
- Escherichia coli plasmid vector PHSG396 (Takara Shuzo: chloramuecole resistance marker) 500 ng of the restriction enzyme PshBI 1 Ounits was reacted at 37 ° C for 1 hour, and then recovered by phenol Z chloroform extraction and ethanol precipitation. After blunting both ends with a tarenow fragment (K1 enow Fragment: manufactured by Takara Shuzo), Mlul linker (Takara Shuzo) was ligated and cyclized using a ligation kit ver. 2 (manufactured by Takara Shuzo), E. coli (DH5a strain) was transformed.
- K1 enow Fragment manufactured by Takara Shuzo
- Mlul linker (Takara Shuzo) was ligated and cyclized using a ligation kit ver. 2 (manufactured by Takara Shuzo), E. coli (DH5a strain) was transformed.
- Plasmid DNA was prepared from the obtained clones by a conventional method, and a clone having a restriction enzyme Mlul cleavage site was selected and named pHSG396 Mlu.
- This SacB gene fragment was digested with the restriction enzyme Mlul, and ligated with a pHSG396Mlu fragment whose terminal was dephosphorylated with alkaline phosphatase (Alkaline Phosphatase Calf intestine: Takara Shuzo) using a ligation kit ver. 2 (Takara Shuzo). DH5a strain).
- the recombinant Escherichia coli thus obtained was spread on an LB agar medium containing 34 gZmL chloramphene-coal. The colonies thus obtained were then transferred to LB agar medium containing 34 / z gZmL chloramphenicol and 10% sucrose and cultured at 37 ° C for 24 hours.
- the kanamycin resistance gene was obtained by PCR using the DNA of Escherichia coli plasmid vector PHSG299 (Takara Shuzo: kanamycin resistance marker) as type III and the synthetic DNAs shown in SEQ ID NO: 3 and SEQ ID NO: 4 as primers.
- Reaction solution composition ⁇ type DNAlng, Pyrobest DNA polymerase (Takara Shuzo) 0.1 ⁇ l 1x concentration attached buffer, 0.5 ⁇ each primer and 0.25 ⁇ MdNTPs were mixed to make a total volume of 20 ⁇ L.
- Reaction temperature conditions 20 cycles of 94 ° C for 20 seconds, 62 ° C for 15 seconds, and 72 ° C for 1 minute and 20 seconds were performed using DNA Thermal Cycler PTC-200 (manufactured by MJ Research). Repeated. However, the heat retention at 94 ° C in the first cycle was 1 minute and 20 seconds, and the heat retention at 72 ° C in the final cycle was 5 minutes.
- the amplification product was confirmed by separation by 0.75% agarose (SeaKem GTG agarose: manufactured by FMC BioProducts) gel electrophoresis, and visualization by chidium bromide staining to detect a fragment of about 1. 1kb. did.
- the target DNA fragment was recovered from the gel using a QIAQuick Gel Extraction Kit (QIAGEN). The recovered DNA fragment was phosphorylated at the 5 ′ end with T4 Polynucleotide Kinase (Takara Shuzo).
- the approximately 3.5 kb DNA fragment obtained by cleaving the pCMBl constructed in the above (C) with restriction enzymes Van91I and Seal was separated and recovered by 0.75% agarose gel electrophoresis. This was mixed with the kanamycin resistance gene prepared in (D) above, ligated using Ligation Kit ver. 2 (Takara Shuzo), and Escherichia coli (DH5a strain) was transformed with the obtained plasmid DNA. .
- the recombinant E. coli thus obtained was spread on an LB agar medium containing 50 gZmL kanamycin.
- a medium (urea 2g, (NH) SO 7g, KH PO 0.5g, K HPO 0.5g, MgSO-7
- the MJ233 strain ratatate dehydrogenase gene was obtained by using the DNA prepared in (A) above as a type III and synthesizing DNA (SEQ ID NO: 5 and SEQ ID NO: 5) designed based on the nucleotide sequence of the gene described in JP-A-11-206385. PCR was performed using No. 6). Reaction solution composition: Type I DNA1 / zL, Taq DNA polymerase (Takara Shuzo) 0.2 l 1x concentration attached buffer, 0.2 M each primer, 0.25 ⁇ M dNTPs were mixed to make a total volume of 20 ⁇ .
- Reaction temperature conditions Using DNA Thermal Cycler PTC-200 (manufactured by MJ Research), a cycle of 94 ° C for 20 seconds, 55 ° C for 20 seconds, and 72 ° C for 1 minute was repeated 30 times. . However, the heat retention at 94 ° C in the first cycle was 1 minute and 20 seconds, and the heat retention at 72 ° C in the final cycle was 5 minutes.
- the amplified product was confirmed by separation by gel electrophoresis of 0.75% agarose (SeaKem GTG agarose: manufactured by FMC BioProducts), and visualization by staining with sodium bromide to detect a fragment of about 0.95 kb.
- the target DNA fragment was recovered from the gel using a QIA Quick Gel Extraction Kit (QIAGEN).
- the recovered DNA fragment was mixed with PCR product closing vector pGEM-TEasy (manufactured by Promega) and ligated using Ligation Kit ver. 2 (manufactured by Takara Shuzo).
- E. coli DH5a strain
- the recombinant E. coli thus obtained was spread on an LB agar medium containing 50 ⁇ g ZmL ampicillin and 50 ⁇ g ZmL X-Gal. Clones that formed white colonies on this medium were subjected to liquid culture by a conventional method, and then plasmid DNA was purified. By cutting the obtained plasmid DNA with restriction enzymes Sacl and Sphl, an insert fragment of about 1. Okb was recognized, which was named pGEMTZCgLDH. Named.
- pGEMTZCgLDH prepared in (B) above with restriction enzymes EcoRV and Xbal
- a coding region for ratate dehydrogenase of about 0.25 kb was cut out.
- the end of the remaining DNA fragment of about 3.7 kb was blunt-ended with a sauce fragment, circularized using Ligation Kit ver.2 (Takara Shuzo), and transformed into Escherichia coli (DH5a strain). .
- the recombinant Escherichia coli thus obtained was spread on an LB agar medium containing 50 gZmL ampicillin.
- the strain grown on this medium was subjected to liquid culture by a conventional method, and then the plasmid DNA was purified.
- the resulting plasmid DNA was digested with restriction enzymes Sacl and Sphl to select a clone in which an inserted fragment of about 0.75 kb was recognized, which was named pGEM TZALDH.
- a DNA fragment of about 0.75 kb generated by digesting the above pGEMTZ A LDH with restriction enzymes Sacl and Sphl was separated and recovered by 0.75% agarose gel electrophoresis, and the ratate containing the defective region was recovered.
- a dehydrogenase gene fragment was prepared. This DNA fragment was mixed with pKMBl constructed in Example 1 digested with restriction enzymes Sacl and Sphl, and ligated using Ligation Kit ver. 2 (Takara Shuzo). E. coli (DH5a strain) was transformed. The recombinant Escherichia coli thus obtained was spread on an LB agar medium containing 50 ⁇ g / mL kanamycin and 50 ⁇ g ZmLX-Gal.
- a clone that formed a white colony on this medium was subjected to liquid culture by a conventional method, and then plasmid DNA was purified.
- the obtained plasmid DNA was cut with restriction enzymes Sacl and Sphl, and those having an inserted fragment of about 0.75 kb were selected and named pKMBlZALDH (FIG. 2).
- Plasmid DNA used for transformation of Brevibatadium 'Flavum MJ-233 strain was also prepared using the E. coli JM110 strain transformed by the calcium chloride method (Journal of Molecular Biology, 53, 159, 1970) using pKMBlZ A LDH. did.
- Brevibacterium flavum strain MJ-233 (FERM BP-1497) is prepared by a conventional method (Wolf Het). al "J. Bacteriol. 1983, 156 (3) 1165-1170, Kurusu Y et al, Agric Biol Chem. 1990, 54 (2) 443-7) to remove (curing) the endogenous plasmid. Plasmid clearing strain Brevibataterum 'Flavum MJ233-ES strain was used for the subsequent transformation. Brevibataterum' Flavum MJ233-ES strain was transformed by an electric pulse method (Res. Microbiol., Vol. 144).
- the resulting transformant was transformed into an LBG agar medium containing 50 ⁇ g ZmL of kanamycin (10 g of tryptone, 5 g of yeast extratato, 5 g of NaCl, 20 g of glucose, and 15 g of agar) in distilled water. [Dissolve in 1L].
- the strain grown on this medium is a plasmid in which pKMBl / ALDH is not replicable in the strain Brevibataterum 'Flavum MJ233-ES, the rat with the ratate dehydrogenase gene and Brevibacterium •
- the homologous recombinant strain was liquid-cultured in an LBG medium containing 50 g / mL of kanamycin. About 1 million cells of this culture solution were spread on an LBG medium containing 10% sucrose. As a result, about 10 strains that were considered to be sucrose-insensitive by dropping the SacB gene by the second homologous recombination were obtained.
- the strains thus obtained include those that have been replaced with a mutant derived from the ratate dehydrogenase gene 3 ⁇ 413 ⁇ 4 ⁇ Bl / ⁇ LDH and those that have returned to the wild type. .
- the cells obtained by liquid culture in LBG medium should be directly subjected to the PCR reaction to detect the ratate dehydrogenase gene. Can be easily confirmed.
- Analysis using the primers (SEQ ID NO: 7 and SEQ ID NO: 8) for amplifying the ratate dehydrogenase gene should reveal a DNA fragment of 720 bp for the wild type and 47 lbp for the mutant having the deletion region. It is.
- a strain having only the mutant gene was selected, and this strain was named Brevibatatellium flavum MJ233Z ALDH.
- This promoter fragment was obtained by synthesizing the Brevibataterium flavum MJ233 genomic DNA prepared in (A) of Example 2 into a ⁇ type and designing it based on the sequence described in SEQ ID NO: 4 of JP-A-7-95891. This was performed by PCR using DNA (SEQ ID NO: 9 and SEQ ID NO: 10).
- Reaction solution composition 1 ⁇ L of type I DNA, 0.2 ⁇ L of Pfx DNA polymerase (manufactured by Invitrogen), 1-fold concentration attached buffer, 0.3 M of each primer, ImM MgSO, 0.25 MdNTPs were mixed to make a total volume of 20 / zL.
- Reaction temperature conditions Using DNA Thermal Cycler PTC-200 (manufactured by MJ Research), a cycle of 94 ° C for 20 seconds, 60 ° C for 20 seconds, and 72 ° C for 30 seconds was repeated 35 times. However, the heat retention at 94 ° C in the first cycle was 1 minute and 20 seconds, and the heat retention at 72 ° C in the final cycle was 2 minutes.
- the amplification products were confirmed by separation by 2.0% agarose (SeaKem GTG agarose: manufactured by FMC BioProducts) gel electrophoresis, and visualization by chidium bromide staining, and a fragment of about 0.25 kb was detected. .
- the target DNA fragment was recovered from the gel using a QIAQuick Gel Extraction Kit (manufactured by QIAGEN).
- the recovered DNA fragment was phosphorylated at the 5 'end with T4 polynucleotide kinase (T4 Polynucleotide Kinase: manufactured by Takara Shuzo), and then used the ligation kit ver. 2 (manufactured by Takara Shuzo) to produce the E.
- the recombinant Escherichia coli thus obtained was spread on an LB agar medium containing 50 ⁇ g ZmL ampicillin and 50 ⁇ g ZmL X-Gal.
- a DNA fragment prepared by cleaving pUCZTZ4 with restriction enzymes BamHI and Pstl was composed of a synthetic DNA (SEQ ID NO: 11 and SEQ ID NO: 12) phosphorylated at the 5 ′ end, and BamHI was added to both ends.
- a DNA linker having a sticky end to Pstl were mixed and ligated using a ligation kit ver. 2 (Takara Shuzo), and Escherichia coli (DH5a strain) was transformed with the obtained plasmid DNA.
- the present DNA linker contains a ribosome binding sequence (A GGAGG) and a closing site (Pad, NotI, Apal) arranged downstream thereof.
- a clone that formed a white colony on this medium was subjected to liquid culture by a conventional method, and then plasmid DNA was purified.
- the obtained plasmid DNA was also selected from those which were cleaved by the restriction enzyme Notl, and named PUCZTZ4-SD.
- the thus constructed pUCZTZ4-SD was digested with the restriction enzyme Pstl, and the ends were blunt-ended with a tarenow fragment. Then, a promoter fragment of about 0.3 kb generated by digestion with the restriction enzyme Kpnl was separated and recovered by 2.0% agarose gel electrophoresis.
- PHSG298par-rep described in JP-A No. 12-93183 is used as a plasmid capable of autonomously replicating stably in coryneform bacteria.
- This plasmid contains the replication region and stabilizing function of the natural plasmid pBY503 carried by Brevibacterium 'statis IFO 12144 strain, the kanamycin resistance gene derived from the E. coli vector PHSG298 (Takara Shuzo) and the replication of E. coli. With an area.
- the strain grown on this medium was subjected to liquid culture by a conventional method, and then the plasmid DNA was purified.
- the resulting plasmid DNA which was cleaved by the neutral restriction enzyme Notl was selected, and the plasmid was named pTZ4 (the construction procedure is shown in FIG. 3).
- Brevibata terium 'Flavum MJ233 strain-derived pyruvate carboxylase gene was obtained using the DNA prepared in (A) of Example 2> as a type I, and the whole genome sequence was reported for the corynebate terium.
- the PCR was performed using synthetic DNAs (SEQ ID NOs: 13 and 14) designed based on the sequence of the gene of Glutamicum ATCC 13032 (GenBank Database Accession No. AP005276).
- reaction solution 1 ⁇ L of type I DNA, 0.2 ⁇ L of Pfx DNA polymerase (manufactured by Invitrogen), 1x attached buffer, 0.3 ⁇ M each primer, ImM MgSO
- DNA thermal cycler Using TC-200 (manufactured by MJ Research), a cycle consisting of 20 seconds at 94 ° C and 4 minutes at 68 ° C was repeated 35 times. However, the heat retention at 94 ° C in the first cycle was 1 minute and 20 seconds, and the heat retention at 68 ° C in the final cycle was 10 minutes. After completion of the PCR reaction, 0.1 L of Takara Ex Taq (Takara Shuzo) was added, and the mixture was further incubated at 72 ° C for 30 minutes.
- the amplification product was confirmed by separation by 0.75% agarose (SeaKem GTG agarose: manufactured by FMC BioProducts) gel electrophoresis and visualization by chidium bromide staining. Detected.
- the target DNA fragment was recovered from the gel using a QIAQuick Gel Extraction Kit (manufactured by QIAGEN).
- the recovered DNA fragment was mixed with a PCR product closing vector pGEM-TEasy (Promega), ligated using Ligation Kit ver. 2 (Takara Shuzo), and Escherichia coli (DH5a strain ) Was transformed.
- the recombinant Escherichia coli thus obtained was spread on an LB agar medium containing 50 ⁇ g ZmL ampicillin and 50 ⁇ g ZmL X-Gal.
- the base sequence of the inserted fragment of pGEMZMJPC was determined using a base sequence decoding device (Model 377XL) manufactured by Applied Biosystems and a big-die terminator one-cycle sequence kit ver3.
- the resulting DNA nucleotide sequence and deduced amino acid sequence are shown in SEQ ID NO: 15. Since this amino acid sequence shows extremely high homology (99.4%) with that of the strain Corynebacterium 'Dartamica ATCC13032', the inserted fragment of pGE M / MJPC was derived from the strain Brevibataerium flavum MJ233 It was determined that the gene was a pyruvate carboxylase gene.
- a pyruvate carboxylase gene fragment having a power of about 3.7 kb generated by cleaving pGEMZMJPC prepared in (A) above with restriction enzymes Pacl and Apal was separated and collected by 0.75% agarose gel electrophoresis.
- This DNA fragment was mixed with pTZ4 constructed in Example 3>, which was to be cleaved with restriction enzymes Pacl and Apal, and ligated. After ligation using Ver. 2 (Takara Shuzo), Escherichia coli (DH5a strain) was transformed with the obtained plasmid DNA. The recombinant E. coli thus obtained was spread on an LB agar medium containing 50 gZmL kanamycin.
- the strain grown on this medium was subjected to liquid culture by a conventional method, and then the plasmid DNA was purified.
- the restriction enzymes Pacl and ApaI By cutting the obtained plasmid DNA with the restriction enzymes Pacl and ApaI, those having an inserted fragment of about 3.7 kb were selected and named pMJPCI (FIG. 4).
- Plasmid DNA for transformation with pMJPCl capable of replication in Brevibatadium 'Flavum MJ233 strain was prepared from E. coli (DH5a strain) transformed in the above (B).
- Brevibacterium flavum strain MJ233Z ⁇ LDH was transformed by the electric pulse method (Res.Microbiol., Vol. 144, p. 181-185, 1993), and the resulting transformant was transformed into 50 ⁇ g ZmL Was spread on a LBG agar medium containing 10 g of tryptone, 5 g of yeast extratato, 5 g of NaCl, 20 g of glucose, and 15 g of agar in 1 L of distilled water.
- the transformed Brevibatate terimum 'Flavam MJ233ZPCZ ⁇ LDH strain obtained in (C) above was cultured overnight in 100 mL of A medium containing 2% dulcose and 25 mg / L kanamycin.
- the obtained cells were collected, washed with 50 ml of 50 mM potassium phosphate buffer (pH 7.5), and suspended again in 20 ml of a buffer having the same composition.
- the suspension was crushed with SONIFIER 350 (manufactured by BRANSON), and the supernatant obtained by centrifugation was used as a cell-free extract.
- the pyruvate carboxylase activity was measured using the obtained cell-free extract.
- Enzyme activity was measured using lOOmM Tris / HCl buffer (pH 7.5), O. lmg / lOmL biotin, 5mM magnesium chloride, 50mM sodium bicarbonate, 5mM sodium pyruvate, 5mM adenosine triphosphate, 0.32mM NADH
- the reaction was carried out at 25 ° C. in a reaction solution containing 20 units / 1.5 ml malate dehydrogenase (manufactured by WAKO, derived from yeast) and the enzyme. 1 U was the amount of enzyme that catalyzes the reduction of 1 ⁇ mol NADH per minute.
- Escherichia coli (Eschericia coli) strain JM109 was cultured in 10 mL of LB medium until the late logarithmic growth phase. Genomic DNA was prepared from the obtained cells by the method shown in Example 1 (A) above.
- the Escherichia coli fumarate reductase gene was obtained based on the DNA prepared in (A) above as type III and the sequence of the gene of Escherichia coli K12-MG1655 (GenBank Database Accession No. U00096), for which the entire genome sequence was reported. PCR was performed using the synthetic DNA (SEQ ID NO: 17 and SEQ ID NO: 18) designed in the above. Reaction solution composition: Type DN Al / z L, Pfx DNA polymerase (Invitrogen) 0.2 L, 1x concentration buffer, 0.3 ⁇ Mix primer, ImM MgSO, 0.25 ⁇ MdNTPs , The whole amount
- Reaction temperature conditions DNA Thermal Cycler Using PTC-200 manufactured by MJ Research, a cycle consisting of 94 ° C for 20 seconds and 68 ° C for 4 minutes was repeated 35 times. However, the heat retention at 94 ° C in the first cycle was 1 minute and 20 seconds, and the heat retention at 68 ° C in the final cycle was 10 minutes. After completion of the PCR reaction, 0.1 L of Takara Ex Taq (Takara Shuzo) was added, and the mixture was further incubated at 72 ° C for 30 minutes.
- the amplification product was confirmed by separation by 0.75% agarose (SeaKem GTG agarose: manufactured by FMC BioProducts) gel electrophoresis, and visualization by chidium bromide staining. Detected. The target DNA fragment was recovered from the gel using a QIAQuick Gel Extraction Kit (manufactured by QIAGEN).
- the recovered DNA fragment was mixed with a PCR product closing vector pT7Blue T—Vector (manufactured by Novagen) and ligated using a ligation kit ver. 2 (manufactured by Takara Shuzo).
- a ligation kit ver. 2 manufactured by Takara Shuzo
- the recombinant E. coli thus obtained was cultured on LB agar medium containing 50 ⁇ g ZmL ampicillin and 50 ⁇ g ZmL X-Gal. Was smeared.
- a clone that formed a white colony on this medium was subjected to liquid culture by a conventional method, and then plasmid DNA was purified.
- By cutting the obtained plasmid DNA with the restriction enzymes Hindlll and Kpnl, an inserted fragment of about 3.9 kb was observed, which was named pFRD6.0.
- nucleotide sequence of the inserted fragment of pFRD6.0 was determined using a nucleotide sequence analyzer (Model 377XL) manufactured by Applied Biosystems and a Big Dye Terminator One Cycle Sequence Kit Ver3. The resulting DNA base sequence and deduced amino acid sequence are described in SEQ ID NOs: 19 and 20-23.
- PMJPC1 constructed in Example 3 was completely cleaved with the restriction enzyme Kpnl, and then reacted with Alkaline Phosphatase Calf intestine (Takara Shuzo). The fragment was mixed with a DNA linker that also had the ability to synthesize 5, phosphorylated synthetic DNA (SEQ ID NO: 24 and SEQ ID NO: 25), and ligated using Ligation Kit ver. 2 (Takara Shuzo). Escherichia coli (DH5 ⁇ strain) was transformed with the DNA. The recombinant E. coli thus obtained was spread on an LB agar medium containing 50 ⁇ g ZmL kanamycin. The strain grown on this medium was subjected to liquid culture by a conventional method, and then the plasmid DNA was purified. From the obtained plasmid DNA, those cut by the restriction enzyme Ndel were selected and named pMJPCl.1.
- the strain grown on this medium was subjected to liquid culture by a conventional method, and then the plasmid DNA was purified.
- the obtained plasmid DNA was fragmented with 505, 2132, 2675, 3775 and 4193 bp by the restriction enzyme Hindlll digestion with the ⁇ 1 '' restriction enzyme. Therefore, it was judged that the structure shown in FIG. was named pFRPCl.1.
- the transformed Brevibatate terium 'Flavam MJ233 / FRD / PC / ALDH strain obtained in the above (B) was cultured overnight in 100 mL of A medium containing 2% glucose and 25 mg / L kanamycin.
- the obtained cells were collected, washed with 50 mL of 50 mM potassium phosphate buffer (pH 7.5), and resuspended in 20 mL of a buffer having the same composition.
- the suspension was crushed with SONIFIER 350 (manufactured by BR ANSON), and the supernatant obtained by centrifugation was used as a cell-free extract.
- the fumarate reductase activity was measured using the obtained cell-free extract.
- Enzyme activity was measured using 33 mM Tris HCl buffer (pH 7.5), O.lmM EDTA, 20 mM Na succinate, 2 mM KFe (CN) and enzyme
- reaction was carried out at 25 ° C in a reaction solution containing 36. 1U is 2 mol K per minute
- the specific activity of fumarate reductase in the effluent was 0.02 U / mg-protein.
- the specific activity was 0.01 U / mg-protein in the cells of the parent strain, MJ233 / ALDH strain, similarly cultured in A medium.
- Urea 4 g, ammonium sulfate: 14 g, potassium monophosphate: 0.5 g, potassium diphosphate 0.5 g, Magnesium sulfate ⁇ heptahydrate: 0.5 g, ferrous sulfate ⁇ heptahydrate: 20 mg, manganese sulfate ⁇ hydrate: 20 mg, D-biotin: 200 ⁇ g, thiamine hydrochloride: 200 ⁇ g, yeast extract : Lg, power Zamino acid: lg, and distilled water: lOOOOmL of medium lOOmL was placed in a 500mL Erlenmeyer flask and sterilized by heating at 120 ° C for 20 minutes.
- the culture solution obtained in the same manner as in Example 7 above was added to the cells collected by centrifugation at 8,000 rpm for 5 minutes, and the OD (660 nm) was adjusted to 200. Suspended. 200 mL of this suspension and 200 mL of a previously sterilized 30% glucose solution were placed in a 1 L jar armmenter, and kept at 35 ° C. A 4M aqueous solution of magnesium hydroxide was added intermittently to keep the pH at 6.8, and the reaction was carried out with aeration at 100 mL / min and stirring at 400 rpm. The average sugar consumption rate at 46 hours after the start of the reaction was 3.22 gZLZh, the succinic acid production rate was 1.38 g / L / h, and the yield was 72%.
- a reaction suspension was prepared in the same manner as described above, and kept at 35 ° C.
- a 4M aqueous solution of magnesium hydroxide was added intermittently so that the pH was maintained at 6.8, and the reaction was carried out with stirring at 200 revolutions per minute without aeration.
- the average sugar consumption rate at 50 hours after the start of the reaction was 2.6 OgZLZh, the succinic acid production rate was 0.90 g / L / h, and the yield was 55%.
- Seed culture was carried out on the Brevibateridium flavum MJ233ZPCZ ⁇ LDH strain prepared in Example 4 in the same manner as in Example 7.
- Glucose 100g
- magnesium sulfate ⁇ heptahydrate 0.5g
- orthophosphoric acid 0.65g
- soybean protein hydrolyzate 0.65g
- ammonium sulfate 1.0g
- sulfuric acid first Iron ⁇ heptahydrate 20 mg
- manganese sulfate 'hydrate 2 Omg
- D-pyotin lmg
- thiamine hydrochloride lmg
- defoamer GD-113: manufactured by NOF Corporation
- the medium was placed in a 300 L jar armmenter and sterilized by heating at 120 ° C. for 20 minutes. After cooling, 450 mL of the above seed culture was inoculated and kept at 30 ° C. Aeration was performed at 113 L / min, pressure was set at 50 kPa, stirring was performed at 280 rpm, and preculture was performed for 20 hours while adjusting the pH to 7.6 with ammonia gas.
- Glucose 100 g
- magnesium sulfate ⁇ heptahydrate 0.5 g of a sugar solution containing 0.5 g in 1 L. Measure each component in an amount equivalent to 260 L, dissolve in 50 L, and heat at 120 ° C for 20 minutes.
- the above-mentioned pre-culture solution was cultivated with 70 L to make a total volume of 260 L, and kept at 30 ° C. Aeration was performed at 113 L / min, pressure was set at 50 kPa, stirring was performed at 140 rpm, and the culture was carried out for 24 hours while adjusting the pH to 7.6 with ammonia gas to obtain cells having a succinic acid-producing ability.
- the bacterial cell solution was concentrated about 4 times with an MF membrane (manufactured by Asahi Kasei Corporation) to obtain a bacterial cell suspension having a dry bacterial body weight of about 60 gZL. The cell suspension was stored at 4 ° C.
- the cell suspension was further concentrated by centrifugation and prepared using the centrifugal supernatant so that the dry cell weight was about 120 gZL.
- Glucose 150 g
- magnesium sulfate ⁇ heptahydrate 0.5 g was dissolved in distilled water to make 300 mL, and sterilized by heating at 120 ° C. for 20 minutes.
- orthophosphoric acid 0.65 g
- ferrous sulfate heptahydrate 20 mg
- manganese sulfate 'hydrate 20 mg
- D-Piotin Lmg
- thiamine hydrochloride lmg
- defoamer GD-113: Dissolve 0.05 mL in about 300 mL of distilled water, adjust the pH to 6.5 with 5N hydroxide solution, and then add distilled water.
- the sample was made up to 450 mL with, and sterilized by heat at 120 ° C for 20 minutes.
- a reaction suspension was prepared in the same manner as in Example 7 above, and the bicarbonate ammonium carbonate was added thereto so that the final concentration was 0.05, 0.1, 0.2, 0.4, 0.8 mol / L.
- the reaction was carried out by adding kamu.
- Table 2 shows the sugar consumption rate, succinic acid production rate, and yield at 20 hours after the start of the reaction. As a result, it was clarified that in the neutralization reaction of magnesium carbonate, by adding an appropriate amount of ammonium bicarbonate, the sugar consumption rate and the succinic acid production rate were significantly increased.
- Adekinol L G294 Asahi Denka
- the sugar consumption rate was 9.80 g / L, h
- the succinic acid production rate was 8.78 g / L / h
- the yield was 96%.
- a suspension for reaction was prepared in the same manner as in Example 12, and ammonium bicarbonate was added thereto so that the final concentration became 0.1 ImolZL, and the reaction was carried out in the same manner.
- glucose was almost consumed.
- the sugar consumption rate was 15.2 gZLZh, and the succinic acid production rate was 12.6 g / L / yield 92%.
- the rate of sugar consumption, the rate of succinic acid production, and the yield were significantly increased by adding an appropriate amount of ammonium bicarbonate in the magnesium carbonate neutralization reaction.
- Adekinol L G294 Asahi Denka
- Urea 4 g, ammonium sulfate: 14 g, 1 potassium phosphate: 0.5 g, 2 potassium phosphate. 5g, magnesium sulfate ⁇ 7hydrate: 0.5g, ferrous sulfate ⁇ 7hydrate: 20mg, manganese sulfate ⁇ Hydrate: 20 mg, D-Piotin: 200 ⁇ g, Thiamine hydrochloride: 200 ⁇ g, Yeast extract: lg, force Zamino acid: lg, and distilled water: 100 mL of culture medium lOOmL into a 500 mL Erlenmeyer flask, 120 ° C, heat sterilized for 20 minutes.
- Urea 12 g, ammonium sulfate: 42 g, monopotassium phosphate: 1.5 g, dipotassium phosphate 1.5 g, magnesium sulfate ⁇ 7 hydrate: 1.5 g, ferrous sulfate ⁇ 7 hydrate : 60mg, manganese sulfate ⁇ Hydrate: 60mg, D-Piotin: 600 ⁇ g, Thiamine hydrochloride: 600g, yeast extract 3g, casamino acid 3g, antifoaming agent (ADEKINOL LG294: made by Asahi Denki): lmL and Distilled water: 2500 mL of the medium was placed in a 5 L fermentor, and sterilized by heating at 120 ° C.
- a reaction suspension was prepared in the same manner as in Comparative Example 1, and the pH was maintained at 7.6 using 2M sodium carbonate, and the reaction was carried out in the same manner. About 12 hours after the start of the reaction, glucose is almost consumed. Had been. The sugar consumption rate was 13 gZLZh and the succinic acid production rate was 7.2 g / L / yield 95%.
- a non-amino organic acid can be produced while keeping the pH of the aqueous medium within a certain range that hardly causes an increase in the volume of the fermentation reaction solution. Furthermore, by adding a monovalent cation to the aqueous medium, the production rate or the yield of the non-amino organic acid can be greatly increased.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04816150.9A EP1672067B1 (en) | 2003-09-17 | 2004-09-17 | Process for producing non-amino organic acid |
JP2005513981A JP4619291B2 (ja) | 2003-09-17 | 2004-09-17 | 非アミノ有機酸の製造方法 |
BRPI0414300-0A BRPI0414300A (pt) | 2003-09-17 | 2004-09-17 | método para produzir ácido orgánico não amino |
US11/376,133 US7563606B2 (en) | 2003-09-17 | 2006-03-16 | Method for producing non-amino organic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003324277 | 2003-09-17 | ||
JP2003-324277 | 2003-09-17 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/376,133 Continuation US7563606B2 (en) | 2003-09-17 | 2006-03-16 | Method for producing non-amino organic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005026349A1 true WO2005026349A1 (ja) | 2005-03-24 |
Family
ID=34308698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/013658 WO2005026349A1 (ja) | 2003-09-17 | 2004-09-17 | 非アミノ有機酸の製造方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7563606B2 (ja) |
EP (1) | EP1672067B1 (ja) |
JP (1) | JP4619291B2 (ja) |
CN (1) | CN1852978A (ja) |
BR (1) | BRPI0414300A (ja) |
WO (1) | WO2005026349A1 (ja) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007046389A1 (ja) * | 2005-10-18 | 2007-04-26 | Ajinomoto Co., Inc. | コハク酸の製造方法 |
WO2007099867A1 (ja) * | 2006-02-24 | 2007-09-07 | Mitsubishi Chemical Corporation | 有機酸生産菌及び有機酸の製造法 |
WO2008143015A1 (ja) | 2007-05-18 | 2008-11-27 | Ajinomoto Co., Inc. | コハク酸およびコハク酸アンモニウム溶液の製造方法 |
US7763447B2 (en) | 2003-08-28 | 2010-07-27 | Ajinomoto Co., Inc. | Method of producing succinic acid with bacterium comprising a modified fumarate reductase gene or a modified succinate dehydrogenase gene |
US7833763B2 (en) | 2003-07-09 | 2010-11-16 | Mitsubishi Chemical Corporation | Method for producing organic acid |
WO2011059031A1 (ja) * | 2009-11-13 | 2011-05-19 | 三菱化学株式会社 | 非アミノ有機酸の製造方法 |
US7972823B2 (en) | 2004-05-20 | 2011-07-05 | Ajinomoto Co., Inc. | Succinic acid-producing bacterium and process for producing succinic acid |
US7985566B2 (en) * | 2005-04-22 | 2011-07-26 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
WO2011111693A1 (ja) | 2010-03-09 | 2011-09-15 | 三菱化学株式会社 | コハク酸の製造方法 |
WO2013069786A1 (ja) | 2011-11-11 | 2013-05-16 | 三菱化学株式会社 | コハク酸の製造方法 |
US9388433B2 (en) | 2011-03-18 | 2016-07-12 | Mitsubishi Chemical Corporation | Method for producing polymer, method for producing organic acid, and organic acid-producing microorganism |
WO2019066017A1 (ja) * | 2017-09-29 | 2019-04-04 | 株式会社親広産業 | 糖消費促進剤 |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7301199B2 (en) * | 2000-08-22 | 2007-11-27 | President And Fellows Of Harvard College | Nanoscale wires and related devices |
EP1669459B1 (en) * | 2003-09-30 | 2014-10-22 | Ajinomoto Co., Inc. | Method of purifying succinic acid from fermentation liquid |
BRPI0510921A (pt) * | 2004-05-20 | 2008-05-20 | Ajinomoto Kk | bactéria produtora de ácido succìnico e processo para produzir ácido succìnico |
WO2008091627A2 (en) | 2007-01-22 | 2008-07-31 | Genomatica, Inc. | Methods and organisms for growth-coupled production of 3-hydroxypropionic acid |
EP2188243A2 (en) | 2007-08-10 | 2010-05-26 | Genomatica, Inc. | Methods for the synthesis of acrylic acid and derivatives from fumaric acid |
EP2192189B1 (en) * | 2007-08-23 | 2018-08-22 | Mitsubishi Chemical Corporation | Method for production of succinic acid at high temperatures |
CN107090424A (zh) | 2008-01-22 | 2017-08-25 | 基因组股份公司 | 利用合成气或其它气态碳源和甲醇的方法和有机体 |
WO2009111672A1 (en) | 2008-03-05 | 2009-09-11 | Genomatica, Inc. | Primary alcohol producing organisms |
EP2265709B1 (en) | 2008-03-27 | 2017-11-08 | Genomatica, Inc. | Microorganisms for the production of adipic acid and other compounds |
AU2009242615A1 (en) * | 2008-05-01 | 2009-11-05 | Genomatica, Inc. | Microorganisms for the production of methacrylic acid |
CA2725549A1 (en) | 2008-06-17 | 2009-12-23 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of fumarate, malate, and acrylate |
KR101767034B1 (ko) * | 2008-12-02 | 2017-08-10 | 푸락 바이오켐 비.브이. | 1가 숙신산 염의 제조방법 |
BRPI0922276A2 (pt) | 2008-12-16 | 2015-08-04 | Genomatica Inc | "organismo microbiano de ocorrência não-natural, e , método para produzir isopropanol, 4-hidroxibutirato,e, 1,4-butanodiol." |
JP2012525156A (ja) | 2009-04-30 | 2012-10-22 | ゲノマチカ, インク. | イソプロパノール、n−ブタノール、及びイソブタノールの産生のための微生物 |
BRPI1013426A2 (pt) | 2009-04-30 | 2016-11-08 | Genomatica Inc | organismos para produção de 1,3-butanodiol |
EP2427544B1 (en) | 2009-05-07 | 2019-07-17 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid |
AU2010248831A1 (en) | 2009-05-15 | 2011-11-24 | Genomatica, Inc. | Organisms for the production of cyclohexanone |
EP2440669A4 (en) | 2009-06-10 | 2013-08-28 | Genomatica Inc | MICROOGANISMS AND PROCEDURES FOR THE CARBON EFFECTIVE BIOSYNTHESIS MEK AND 2-BUTANOL |
WO2011017560A1 (en) | 2009-08-05 | 2011-02-10 | Genomatica, Inc. | Semi-synthetic terephthalic acid via microorganisms that produce muconic acid |
MX2012003025A (es) | 2009-09-09 | 2012-06-27 | Genomatica Inc | Microorganismos y metodos para la co-produccion de isopropanol con alcoholes, dioles y acidos primarios. |
CN102762735B (zh) | 2009-10-13 | 2016-08-03 | 基因组股份公司 | 生产1,4-丁二醇、4-羟基丁醛、4-羟基丁酰-coa、腐胺和相关化合物的微生物及其相关方法 |
EP2491125A4 (en) | 2009-10-23 | 2014-04-23 | Genomatica Inc | MICROORGANISMS FOR ANILINE PRODUCTION |
MX2012006602A (es) | 2009-12-10 | 2012-08-01 | Genomatica Inc | Metodos y organismos para convertir el gas de sintesis u otras fuentes de carbono gaseoso y metanol a 1, 3 - butanodiol. |
WO2011082378A2 (en) | 2009-12-31 | 2011-07-07 | Myriant Technologies Llc | Purification of succinic acid from the fermentation broth containing ammonium succinate |
KR20120123742A (ko) | 2010-01-29 | 2012-11-09 | 게노마티카 인코포레이티드 | P-톨루에이트 및 테레프탈레이트 생합성 미생물 및 생합성 방법 |
US8048661B2 (en) | 2010-02-23 | 2011-11-01 | Genomatica, Inc. | Microbial organisms comprising exogenous nucleic acids encoding reductive TCA pathway enzymes |
US8445244B2 (en) | 2010-02-23 | 2013-05-21 | Genomatica, Inc. | Methods for increasing product yields |
US9023636B2 (en) | 2010-04-30 | 2015-05-05 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of propylene |
EP2566969B1 (en) | 2010-05-05 | 2019-09-04 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of butadiene |
CN103025877A (zh) | 2010-07-26 | 2013-04-03 | 基因组股份公司 | 用于生物合成芳族化合物、2,4-戊二烯酸和1,3-丁二烯的微生物和方法 |
CA2807102C (en) * | 2010-07-31 | 2018-08-21 | Myriant Corporation | Improved fermentation process for the production of organic acids |
AU2013334175B2 (en) | 2012-10-26 | 2017-09-28 | Massachusetts Institute Of Technology | Humidity control in chemical reactors |
SG11201502917TA (en) * | 2012-10-26 | 2015-05-28 | Massachusetts Inst Technology | Control of carbon dioxide levels and ph in small volume reactors |
CA3173080A1 (en) | 2013-08-23 | 2015-02-26 | Sanofi | Small volume bioreactors with substantially constant working volumes and associated systems and methods |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0372891A (ja) * | 1989-08-11 | 1991-03-28 | Nippon Synthetic Chem Ind Co Ltd:The | ソルビン酸の製造方法 |
JPH11196888A (ja) * | 1998-01-16 | 1999-07-27 | Mitsubishi Chemical Corp | ピルビン酸カルボキシラーゼ遺伝子組み換え菌体による有機酸の製造法 |
JP2000037196A (ja) * | 1998-07-24 | 2000-02-08 | Musashino Chemical Laboratory Ltd | アンモニア耐性l(+)−乳酸産生能菌およびl(+)−乳酸の生産方法 |
JP2003199522A (ja) * | 2002-01-09 | 2003-07-15 | Inobakkusu Kk | 食用調味料 |
JP2003235592A (ja) * | 2002-02-13 | 2003-08-26 | Mitsubishi Chemicals Corp | 有機酸の製造方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4282255A (en) * | 1979-06-28 | 1981-08-04 | State Of Oregon, By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Method and starter compositions for the growth of acid producing bacteria and bacterial compositions produced thereby |
JPS61209596A (ja) | 1985-03-12 | 1986-09-17 | Kanegafuchi Chem Ind Co Ltd | 固定化微生物による有機酸の製法 |
JPH0636746B2 (ja) | 1985-08-24 | 1994-05-18 | 味の素株式会社 | L―グルタミン酸の製造方法 |
JPH0796522B2 (ja) | 1986-04-08 | 1995-10-18 | 軽質留分新用途開発技術研究組合 | カルボン酸アンモニウム水溶液からのカルボン酸の製造法 |
JPS62238232A (ja) | 1986-04-09 | 1987-10-19 | Res Assoc Util Of Light Oil | カルボン酸アンモニウム水溶液からのカルボン酸の製造法 |
ES2036188T3 (es) | 1986-06-11 | 1993-05-16 | Michigan Biotechnology Institute | Un procedimiento para la produccion de acido succinico por fermentacion anaerobia. |
US5143834A (en) | 1986-06-11 | 1992-09-01 | Glassner David A | Process for the production and purification of succinic acid |
US5168055A (en) * | 1986-06-11 | 1992-12-01 | Rathin Datta | Fermentation and purification process for succinic acid |
US5034105A (en) | 1989-07-27 | 1991-07-23 | Michigan Biotechnology Institute | Carboxylic acid purification and crystallization process |
US5142834A (en) * | 1990-07-12 | 1992-09-01 | Donnelly Corporation | Vehicle trim assembly and fastener therefor |
US5132456A (en) * | 1991-05-07 | 1992-07-21 | The Regents Of The University Of California | Sorption of carboxylic acid from carboxylic salt solutions at PHS close to or above the pKa of the acid, with regeneration with an aqueous solution of ammonia or low-molecular-weight alkylamine |
JP2526836B2 (ja) | 1991-08-23 | 1996-08-21 | 味の素株式会社 | 酢酸資化性遺伝子 |
JP2844511B2 (ja) | 1993-09-02 | 1999-01-06 | 味の素株式会社 | 酢酸資化性遺伝子及びその利用 |
JP3394593B2 (ja) | 1994-05-11 | 2003-04-07 | 昭和高分子株式会社 | 生分解性脂肪族ポリエステルの製造方法 |
US5504004A (en) * | 1994-12-20 | 1996-04-02 | Michigan Biotechnology Institute | Process for making succinic acid, microorganisms for use in the process and methods of obtaining the microorganisms |
US5770435A (en) * | 1995-11-02 | 1998-06-23 | University Of Chicago | Mutant E. coli strain with increased succinic acid production |
US5869301A (en) * | 1995-11-02 | 1999-02-09 | Lockhead Martin Energy Research Corporation | Method for the production of dicarboxylic acids |
KR19990013007A (ko) * | 1997-07-31 | 1999-02-25 | 박원훈 | 형질전환된 대장균 ss373(kctc 8818p)과 이를 이용한숙신산의 생산방법 |
US5958744A (en) * | 1997-08-18 | 1999-09-28 | Applied Carbochemicals | Succinic acid production and purification |
JP4197754B2 (ja) | 1997-10-09 | 2008-12-17 | 三菱化学株式会社 | 乳酸又はコハク酸の製造方法 |
JP3480274B2 (ja) | 1997-10-29 | 2003-12-15 | 三菱化学株式会社 | 脂肪族ポリエステル共重合体の製造方法 |
JPH11196887A (ja) | 1998-01-16 | 1999-07-27 | Mitsubishi Chemical Corp | ホスホエノールピルビン酸カルボキシラーゼ遺伝子組み換え菌体による有機酸の製造法 |
JP4074365B2 (ja) | 1998-01-28 | 2008-04-09 | 三菱化学株式会社 | ラクテートデヒドロゲナーゼ遺伝子及び該遺伝子破壊株 |
US20030087381A1 (en) * | 1998-04-13 | 2003-05-08 | University Of Georgia Research Foundation, Inc. | Metabolically engineered organisms for enhanced production of oxaloacetate-derived biochemicals |
EP1073722B1 (en) | 1998-04-13 | 2010-02-17 | The University Of Georgia Research Foundation, Inc. | Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells |
DE19951975A1 (de) * | 1999-10-28 | 2001-05-03 | Degussa | Neue für das poxB-Gen codierende Nuleotidsequenzen |
DE19959650A1 (de) | 1999-12-10 | 2001-06-13 | Degussa | Neue für die Gene sdhA, sdhB und sdhC codierende Nukleotidsequenzen |
JP4623825B2 (ja) * | 1999-12-16 | 2011-02-02 | 協和発酵バイオ株式会社 | 新規ポリヌクレオチド |
US6670505B1 (en) | 2000-03-07 | 2003-12-30 | Eastman Chemical Company | Process for the recovery of organic acids from aqueous solutions |
US6911329B2 (en) * | 2000-09-23 | 2005-06-28 | Degussa Ag | Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria |
EP1320586B1 (en) | 2000-09-30 | 2004-08-25 | Degussa AG | Process for the fermentative preparation of d-pantothenic acid using coryneform bacteria |
AU2002215910A1 (en) | 2000-11-04 | 2002-05-15 | Degussa Ag | Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family |
DE10112102A1 (de) | 2001-03-14 | 2002-09-19 | Degussa | Verfahren zur fermentativen Herstellung von D-Pantothensäure und/oder deren Salzen |
US6743610B2 (en) * | 2001-03-30 | 2004-06-01 | The University Of Chicago | Method to produce succinic acid from raw hydrolysates |
JP2002291477A (ja) | 2001-03-30 | 2002-10-08 | Mitsubishi Chemicals Corp | フマラーゼをコードするdna及びその利用 |
DE60216029T2 (de) * | 2001-09-26 | 2007-06-21 | Kabushiki Kaisha Toshiba | Copolymer-Harzzusammensetzung und Verfahren zu seiner Herstellung |
JP3754014B2 (ja) | 2001-09-26 | 2006-03-08 | 株式会社東芝 | 共重合体樹脂組成物およびその製造方法 |
DE10154175A1 (de) | 2001-11-05 | 2003-05-15 | Basf Ag | Gene die für Homeostase-und Adaptions-Proteine codieren |
JP4032765B2 (ja) | 2002-02-13 | 2008-01-16 | 三菱化学株式会社 | 有機酸の製造方法 |
JP4469568B2 (ja) | 2003-07-09 | 2010-05-26 | 三菱化学株式会社 | 有機酸の製造方法 |
CN100575496C (zh) * | 2003-08-28 | 2009-12-30 | 三菱化学株式会社 | 产生琥珀酸的方法 |
EP1669459B1 (en) | 2003-09-30 | 2014-10-22 | Ajinomoto Co., Inc. | Method of purifying succinic acid from fermentation liquid |
WO2005113744A1 (ja) | 2004-05-20 | 2005-12-01 | Ajinomoto Co., Inc. | コハク酸生産菌及びコハク酸の製造方法 |
BRPI0510921A (pt) | 2004-05-20 | 2008-05-20 | Ajinomoto Kk | bactéria produtora de ácido succìnico e processo para produzir ácido succìnico |
-
2004
- 2004-09-17 JP JP2005513981A patent/JP4619291B2/ja not_active Expired - Fee Related
- 2004-09-17 EP EP04816150.9A patent/EP1672067B1/en not_active Expired - Fee Related
- 2004-09-17 CN CNA2004800268683A patent/CN1852978A/zh active Pending
- 2004-09-17 WO PCT/JP2004/013658 patent/WO2005026349A1/ja active Application Filing
- 2004-09-17 BR BRPI0414300-0A patent/BRPI0414300A/pt not_active Application Discontinuation
-
2006
- 2006-03-16 US US11/376,133 patent/US7563606B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0372891A (ja) * | 1989-08-11 | 1991-03-28 | Nippon Synthetic Chem Ind Co Ltd:The | ソルビン酸の製造方法 |
JPH11196888A (ja) * | 1998-01-16 | 1999-07-27 | Mitsubishi Chemical Corp | ピルビン酸カルボキシラーゼ遺伝子組み換え菌体による有機酸の製造法 |
JP2000037196A (ja) * | 1998-07-24 | 2000-02-08 | Musashino Chemical Laboratory Ltd | アンモニア耐性l(+)−乳酸産生能菌およびl(+)−乳酸の生産方法 |
JP2003199522A (ja) * | 2002-01-09 | 2003-07-15 | Inobakkusu Kk | 食用調味料 |
JP2003235592A (ja) * | 2002-02-13 | 2003-08-26 | Mitsubishi Chemicals Corp | 有機酸の製造方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1672067A4 * |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7833763B2 (en) | 2003-07-09 | 2010-11-16 | Mitsubishi Chemical Corporation | Method for producing organic acid |
US7763447B2 (en) | 2003-08-28 | 2010-07-27 | Ajinomoto Co., Inc. | Method of producing succinic acid with bacterium comprising a modified fumarate reductase gene or a modified succinate dehydrogenase gene |
US7972823B2 (en) | 2004-05-20 | 2011-07-05 | Ajinomoto Co., Inc. | Succinic acid-producing bacterium and process for producing succinic acid |
US8021864B2 (en) | 2005-04-22 | 2011-09-20 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
US9080009B2 (en) | 2005-04-22 | 2015-07-14 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
US11732087B2 (en) | 2005-04-22 | 2023-08-22 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
US10870727B2 (en) | 2005-04-22 | 2020-12-22 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
US10287393B2 (en) | 2005-04-22 | 2019-05-14 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
US7985566B2 (en) * | 2005-04-22 | 2011-07-26 | Mitsubishi Chemical Corporation | Biomass-resource-derived polyester and production process thereof |
JP5088136B2 (ja) * | 2005-10-18 | 2012-12-05 | 味の素株式会社 | コハク酸の製造方法 |
US7829316B2 (en) | 2005-10-18 | 2010-11-09 | Ajinomoto Co., Inc. | Process for production of succinic acid |
WO2007046389A1 (ja) * | 2005-10-18 | 2007-04-26 | Ajinomoto Co., Inc. | コハク酸の製造方法 |
WO2007099867A1 (ja) * | 2006-02-24 | 2007-09-07 | Mitsubishi Chemical Corporation | 有機酸生産菌及び有機酸の製造法 |
US8034975B2 (en) | 2007-05-18 | 2011-10-11 | Ajinomoto Co., Inc. | Method of manufacturing succinic acid and ammonium succinate solutions |
WO2008143015A1 (ja) | 2007-05-18 | 2008-11-27 | Ajinomoto Co., Inc. | コハク酸およびコハク酸アンモニウム溶液の製造方法 |
JP5810412B2 (ja) * | 2009-11-13 | 2015-11-11 | 三菱化学株式会社 | 非アミノ有機酸の製造方法 |
WO2011059031A1 (ja) * | 2009-11-13 | 2011-05-19 | 三菱化学株式会社 | 非アミノ有機酸の製造方法 |
WO2011111693A1 (ja) | 2010-03-09 | 2011-09-15 | 三菱化学株式会社 | コハク酸の製造方法 |
US9388433B2 (en) | 2011-03-18 | 2016-07-12 | Mitsubishi Chemical Corporation | Method for producing polymer, method for producing organic acid, and organic acid-producing microorganism |
US10077456B2 (en) | 2011-03-18 | 2018-09-18 | Mitsubishi Chemical Corporation | Method for producing polymer, method for producing organic acid, and organic acid-producing microorganism |
WO2013069786A1 (ja) | 2011-11-11 | 2013-05-16 | 三菱化学株式会社 | コハク酸の製造方法 |
WO2019066017A1 (ja) * | 2017-09-29 | 2019-04-04 | 株式会社親広産業 | 糖消費促進剤 |
JPWO2019066017A1 (ja) * | 2017-09-29 | 2020-10-22 | 株式会社親広産業 | 糖消費促進剤 |
Also Published As
Publication number | Publication date |
---|---|
EP1672067B1 (en) | 2015-11-11 |
US20060281156A1 (en) | 2006-12-14 |
BRPI0414300A (pt) | 2006-11-07 |
JPWO2005026349A1 (ja) | 2007-11-08 |
JP4619291B2 (ja) | 2011-01-26 |
US7563606B2 (en) | 2009-07-21 |
EP1672067A1 (en) | 2006-06-21 |
CN1852978A (zh) | 2006-10-25 |
EP1672067A4 (en) | 2011-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005026349A1 (ja) | 非アミノ有機酸の製造方法 | |
JP4575086B2 (ja) | コハク酸の製造方法 | |
EP1672077B1 (en) | Process for producing succinic acid | |
JP5180060B2 (ja) | 有機酸生産菌及び有機酸の製造法 | |
JP4760121B2 (ja) | コハク酸の製造方法 | |
JP5023701B2 (ja) | コハク酸生産菌及びコハク酸の製造方法 | |
JP5572279B2 (ja) | コハク酸生産菌及びコハク酸の製造方法 | |
WO2007046389A1 (ja) | コハク酸の製造方法 | |
JP5034630B2 (ja) | 有機酸生産微生物の菌体の調製法及び有機酸の製造法 | |
JP5602982B2 (ja) | コハク酸の製造方法 | |
JP2009065972A (ja) | コハク酸の製造方法 | |
US10179903B2 (en) | Microorganism having L-lysine producing ability and L-lysine producing method using same | |
JP2008067623A (ja) | 非アミノ有機酸の製造方法 | |
JP4428999B2 (ja) | 非アミノ有機酸の製造方法 | |
JP4720114B2 (ja) | オキザロ酢酸またはオキザロ酢酸誘導体の製造方法 | |
JP5034395B2 (ja) | 有機酸生産菌及び有機酸の製造方法 | |
JP5663859B2 (ja) | 非アミノ有機酸生産菌および非アミノ有機酸の製造方法 | |
JP2008067624A (ja) | 非アミノ有機酸の製造方法 | |
JP2008067627A (ja) | 非アミノ有機酸生産菌および非アミノ有機酸の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480026868.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11376133 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005513981 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004816150 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004816150 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0414300 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 11376133 Country of ref document: US |